Caxton Advantage Life Sciences Fund logo

Caxton Advantage Life Sciences Fund

North America, New York, United States, New York

Description

Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.

Investor Profile

Caxton Advantage Life Sciences Fund has made 14 investments, with 0 in the past 12 months and 43% as lead.

Stage Focus

  • Series C (29%)
  • Series D (14%)
  • Series E (14%)
  • Post Ipo Equity (14%)
  • Private Equity (14%)
  • Series Unknown (14%)

Country Focus

  • United States (79%)
  • Canada (21%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Oncology
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caxton Advantage Life Sciences Fund frequently co-invest with?

ProQuest Investments
North America, New Jersey, United States, Princeton
Co-Investments: 3
Domain Associates
North America, California, United States, San Diego
Co-Investments: 4
Sanderling Ventures
North America, California, United States, San Mateo
Co-Investments: 3
The Aurora Funds
North America, North Carolina, United States, Durham
Co-Investments: 3
CHL Medical Partners
North America, Connecticut, United States, Stamford
Co-Investments: 4
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Baxter Ventures
North America, Illinois, United States, Deerfield
Co-Investments: 1
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 5

What are some of recent deals done by Caxton Advantage Life Sciences Fund?

VIVUS

Mountain View, California, United States

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products

BiopharmaBiotechnologyHealth Care
Post Ipo EquityNov 20, 2020
Amount Raised: $33,600,000
Mevion Medical Systems

Littleton, Massachusetts, United States

Mevion Medical Systems develops radiation therapies for the treatment of cancer.

BiotechnologyHealth CareTherapeutics
Private EquityAug 4, 2014
Amount Raised: $200,000,000
Mevion Medical Systems

Littleton, Massachusetts, United States

Mevion Medical Systems develops radiation therapies for the treatment of cancer.

BiotechnologyHealth CareTherapeutics
Private EquityJun 25, 2013
Amount Raised: $55,000,000
Regado Biosciences

Durham, North Carolina, United States

Regado Biosciences develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.

BiotechnologyHealth CareTherapeutics
Series EDec 17, 2012
Amount Raised: $51,000,000
Gemin X Pharmaceuticals

Montréal, Quebec, Canada

Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.

BiotechnologyPharmaceuticalTherapeutics
Series EAug 24, 2010
Amount Raised: $8,000,000
Gemin X Pharmaceuticals

Montréal, Quebec, Canada

Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.

BiotechnologyPharmaceuticalTherapeutics
Series DApr 20, 2010
Amount Raised: $16,000,000
Regado Biosciences

Durham, North Carolina, United States

Regado Biosciences develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.

BiotechnologyHealth CareTherapeutics
Series DDec 17, 2009
Amount Raised: $40,000,000
Sunesis Pharmaceuticals

South San Francisco, California, United States

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

BiotechnologyHealth CareOncologyPharmaceutical
Post Ipo EquityApr 7, 2009
Amount Raised: $43,500,000
Mevion Medical Systems

Littleton, Massachusetts, United States

Mevion Medical Systems develops radiation therapies for the treatment of cancer.

BiotechnologyHealth CareTherapeutics
Series UnknownJan 1, 2009
Amount Raised: $33,000,000
Anthera Pharmaceuticals

Hayward, California, United States

Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.

BiotechnologyHealth CarePharmaceutical
Series UnknownAug 14, 2008
Amount Raised: $19,000,000